• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

曾接受冠状动脉旁路移植术患者的经皮血管重建。即刻及1年临床结局。

Percutaneous revascularization in patients with previous coronary artery bypass graft surgery. Immediate and 1-year clinical outcomes.

作者信息

Tejada Julio G, Velazquez Maite, Hernandez Felipe, Albarran Agustín, Gomez Ivan, Rodriguez Sergio, Andreu Javier, Tascon Juan

机构信息

Servicio de Cardiología, Hospital doce de Octubre, Madrid, Spain.

出版信息

Int J Cardiol. 2009 May 15;134(2):201-6. doi: 10.1016/j.ijcard.2008.01.042. Epub 2008 May 27.

DOI:10.1016/j.ijcard.2008.01.042
PMID:18508141
Abstract

BACKGROUND

An increasing number of patients undergoing percutaneous interventions (PI) have experienced previous coronary artery bypass graft surgery (CABG). However, the impact of PI on outcomes in such patients is currently unclear. We evaluated the immediate and 1-year clinical outcomes of post-CABG patients who underwent PI in a tertiary center.

METHODS

From January-2005 to September-2006, 91 consecutive post-CABG patients underwent 197 stent implantations (84% drug-eluting stents) for 154 lesions. 58% were treated in the native coronary arteries, 34% in the grafts and 8% in both type of vessels. Major adverse cardiac events (MACE) were recorded in-hospital and at 1-year follow-up.

RESULTS

Procedural success rate was 95.6%. In-hospital MACE rate was 3.3%. At 1 year, the incidence of MACE was 18.6%: death occurred in 5.4% of the patients, myocardial infarction in 2.2%, and 10.9% of the patients underwent repeat revascularization (target lesion revascularization was required in 5.4%). Multivariate analysis revealed left ventricular ejection fraction <50% (OR 4.6, 95% CI 1.8 to 7.5, p=0.01) and multivessel intervention (OR 2.7, 95% CI 1.2 to 4.5, p=0.03) to be independent predictors of MACE at 1 year.

CONCLUSIONS

Immediate results showed the safety and efficacy of percutaneous revascularization in post-CABG patients. The relatively low risk need for target lesion revascularization obtained is encouraging. Independent predictors of MACE at 1 year were left ventricular disfunction and multivessel intervention.

摘要

背景

越来越多接受经皮介入治疗(PI)的患者曾接受过冠状动脉旁路移植术(CABG)。然而,目前PI对此类患者预后的影响尚不清楚。我们评估了在一家三级中心接受PI的CABG术后患者的即刻及1年临床预后。

方法

2005年1月至2006年9月,91例连续的CABG术后患者因154处病变接受了197次支架植入(84%为药物洗脱支架)。58%在自身冠状动脉进行治疗,34%在移植血管,8%在两种血管。记录住院期间及1年随访时的主要不良心脏事件(MACE)。

结果

手术成功率为95.6%。住院期间MACE发生率为3.3%。1年时,MACE发生率为18.6%:5.4%的患者死亡,2.2%发生心肌梗死,10.9%的患者接受了再次血运重建(5.4%需要靶病变血运重建)。多因素分析显示左心室射血分数<50%(OR 4.6,95%CI 1.8至7.5,p=0.01)和多支血管介入(OR 2.7,95%CI 1.2至4.5,p=0.03)是1年时MACE的独立预测因素。

结论

即刻结果显示了CABG术后患者经皮血运重建的安全性和有效性。获得的相对较低的靶病变血运重建风险令人鼓舞。1年时MACE的独立预测因素是左心室功能障碍和多支血管介入。

相似文献

1
Percutaneous revascularization in patients with previous coronary artery bypass graft surgery. Immediate and 1-year clinical outcomes.曾接受冠状动脉旁路移植术患者的经皮血管重建。即刻及1年临床结局。
Int J Cardiol. 2009 May 15;134(2):201-6. doi: 10.1016/j.ijcard.2008.01.042. Epub 2008 May 27.
2
Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.药物洗脱支架与冠状动脉搭桥手术治疗多支冠状动脉疾病的比较:单机构三年随访结果
Circulation. 2009 Apr 21;119(15):2040-50. doi: 10.1161/CIRCULATIONAHA.108.819730. Epub 2009 Apr 6.
3
Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.药物、血管成形术或手术研究(MASS II)的五年随访:一项针对多支冠状动脉疾病三种治疗策略的随机对照临床试验
Circulation. 2007 Mar 6;115(9):1082-9. doi: 10.1161/CIRCULATIONAHA.106.625475.
4
Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.药物洗脱支架适用于大冠状动脉吗?来自多中心经皮冠状动脉介入治疗注册研究的见解。
Int J Cardiol. 2008 Nov 28;130(3):374-9. doi: 10.1016/j.ijcard.2008.06.046. Epub 2008 Aug 15.
5
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.药物洗脱支架时代大隐静脉桥血管支架辅助经皮治疗的短期和长期疗效
Am J Cardiol. 2008 Jan 1;101(1):63-8. doi: 10.1016/j.amjcard.2007.07.048. Epub 2007 Nov 19.
6
Percutaneous revascularization of ostial saphenous vein graft stenoses.隐静脉桥开口处狭窄的经皮血管重建术。
J Am Coll Cardiol. 1995 Oct;26(4):955-60. doi: 10.1016/0735-1097(95)00266-X.
7
Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.药物洗脱支架植入经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗多支冠状动脉疾病后的长期死亡率。
Circulation. 2008 Apr 22;117(16):2079-86. doi: 10.1161/CIRCULATIONAHA.107.750109. Epub 2008 Apr 14.
8
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study).药物洗脱支架治疗无保护左主干病变后再狭窄的发生率及处理:来自718例患者队列(左主干研究失败,FAILS)中的70例再狭窄病例
J Am Coll Cardiol. 2009 Sep 22;54(13):1131-6. doi: 10.1016/j.jacc.2009.06.018.
9
Use of stents for small coronary arteries. Results of the Multi-Link 2.5 Portuguese Registry.小型冠状动脉支架的应用。多链接2.5葡萄牙注册研究结果。
Rev Port Cardiol. 2001 Sep;20(9):819-37.
10
Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.糖尿病患者与非糖尿病患者的多支冠状动脉血运重建:ARTS-II(动脉血运重建治疗研究 - 第二部分)试验的3年随访
J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010.

引用本文的文献

1
Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge.药物洗脱支架再狭窄:经典挑战的现代应对策略。
Curr Cardiol Rev. 2023;19(3):e030123212355. doi: 10.2174/1573403X19666230103154638.
2
Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease.第二代药物洗脱支架置入术与冠状动脉旁路移植术治疗左主干和/或多支血管病变的年轻患者。
J Interv Cardiol. 2020 Apr 20;2020:6736704. doi: 10.1155/2020/6736704. eCollection 2020.
3
Long-term outcomes of percutaneous coronary intervention in grafts and native vessels in coronary artery bypass grafting patients with diabetes mellitus.
糖尿病冠状动脉旁路移植术患者移植血管和自身血管经皮冠状动脉介入治疗的长期预后
J Thorac Dis. 2019 Nov;11(11):4798-4806. doi: 10.21037/jtd.2019.10.33.
4
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.既往冠状动脉旁路移植术后患者应用新一代药物洗脱支架的长期预后。
J Am Heart Assoc. 2018 Jan 30;7(3):e007212. doi: 10.1161/JAHA.117.007212.
5
Immediate results and six-month clinical outcome after percutaneous coronary intervention in patients with prior coronary artery bypass surgery.曾接受冠状动脉搭桥手术患者经皮冠状动脉介入治疗后的即时结果及六个月临床结局
J Tehran Heart Cent. 2011 Winter;6(1):31-6. Epub 2011 Feb 28.